Lee Susan J, Kavanaugh Arthur
Division of Rheumatology, Allergy, and Immunology, University of California, San Diego, La Jolla, CA 92093-0943, USA.
J Allergy Clin Immunol. 2005 Oct;116(4):900-5. doi: 10.1016/j.jaci.2005.03.028.
In recent years, a growing number of biologic agents have become available for the treatment of various autoimmune, neoplastic, cardiovascular, infectious, allergic, and other conditions. Their introduction has resulted in marked clinical improvements for many patients. Nevertheless, a variety of adverse reactions have been observed with these agents. Because many biologic agents affect key components of sundry physiologic processes, a number of important adverse reactions might be considered mechanism based. Other adverse reactions relate to the agent rather than the target, including hypersensitivity reactions. As a means of exploring the spectrum of potential adverse effects related to biologic agents and their mechanisms, this review will focus on the experience to date with biologic agents used for the treatment of autoimmune disorders. An understanding of the spectrum and types of reactions possible with biologic agents, as well as the mechanisms underlying such reactions, will help clinicians use them optimally.
近年来,越来越多的生物制剂可用于治疗各种自身免疫性、肿瘤性、心血管性、感染性、过敏性及其他疾病。它们的应用已使许多患者在临床上有显著改善。然而,使用这些制剂时观察到了多种不良反应。由于许多生物制剂会影响各种生理过程的关键组成部分,一些重要的不良反应可能被认为是基于机制的。其他不良反应与制剂本身而非靶点有关,包括超敏反应。作为探索与生物制剂相关的潜在不良反应谱及其机制的一种方式,本综述将聚焦于迄今为止使用生物制剂治疗自身免疫性疾病的经验。了解生物制剂可能出现的反应谱和类型,以及这些反应背后的机制,将有助于临床医生优化使用它们。